https://allsci.com/news/regulatory/fda-fast-track-peanut-allergy-immunotherapy/ AllScien 2026-08-03T16:36:09.988035Z Aravax secures FDA Fast Track designation for PVX108 peanut allergy immunotherapy https://allsci.com/news/funding/annamycin-aml-trial-funding-moleculin-raises-usd/ AllScien 2026-08-03T16:01:35.319797Z Moleculin raises USD 9.3m to fund Annamycin's pivotal AML trial through interim readout https://allsci.com/news/licensing-and-partnerships/tadekinig-alfa-us-commercialization-nippon/ AllScien 2026-08-03T14:54:24.205810Z Nippon Shinyaku exercises USD 30 million option for AB2 Bio's rare disease biologic https://allsci.com/news/business/supernus-indivior-merger-and-to-build-usd-22/ AllScien 2026-08-03T14:36:27.060202Z Supernus, Indivior agree all-stock merger to create diversified CNS biopharma https://allsci.com/news/regulatory/olomorasib-fda-breakthrough-pancreatic-cancer/ AllScien 2026-08-03T13:56:51.724041Z Lilly's olomorasib earns FDA Breakthrough Therapy designation for KRAS G12C pancreatic cancer https://allsci.com/news/business/curium-lantheus-acquisition-acquires-for-usd-8b/ AllScien 2026-08-03T13:41:28.188926Z Curium to acquire Lantheus for USD 8b to build global radiopharmaceutical powerhouse https://allsci.com/news/venture-financing/sarna-pipeline-funding-ractigen-raises-usd-31m-to/ AllScien 2026-08-03T13:20:33.463375Z China's Ractigen raises USD 31m to expand saRNA pipeline https://allsci.com/news/regulatory/ism8969-nmpa-ind-approval-parkinsons-insilico/ AllScien 2026-08-03T12:59:49.582846Z China clears Insilico's BBB-penetrant NLRP3 inhibitor for Parkinson's Phase I study https://allsci.com/news/licensing-and-partnerships/electronic-genome-mapping-aml-mds-nabsys-expands/ AllScien 2026-08-03T12:54:47.163475Z Nabsys expands electronic genome mapping into AML and MDS through Indiana University partnership https://allsci.com/news/approvals/pluvicto-prostate-cancer-approval-fda-approves-in/ AllScien 2026-08-03T12:50:15.775321Z FDA approves Pluvicto in earlier-stage prostate cancer, expanding Novartis's radioligand franchise https://allsci.com/news/venture-financing/ratio-therapeutics-series-c-funding-raises-usd/ AllScien 2026-08-03T12:37:25.191866Z Ratio Therapeutics raises USD 70m Series C with Eli Lilly as new strategic investor https://allsci.com/news/debt-financing/annexon-credit-facility-funding-secures-usd-200m/ AllScien 2026-08-03T12:25:53.814058Z Annexon secures USD 200m credit facility as late-stage programs approach market approvals https://allsci.com/news/clinical-trials/bristol-myers-squibb-pipeline-delays-milvexian/ AllScien 2026-08-03T12:16:14.082444Z BMS Q2'26: Milvexian slips as admilparant becomes the key catalyst https://allsci.com/news/earnings-call-insights/abbvie-q2-earnings-guidance-raises-full-year-on/ AllScien 2026-08-03T11:08:18.630013Z AbbVie Q2'26: Etentamig nears regulatory test while Temab-A broadens oncology ambitions https://allsci.com/news/clinical-trials/sanofi-atopic-dermatitis-halts-asset-despite/ AllScien 2026-08-03T10:57:53.729760Z Sanofi Q2'26: Pipeline review claims amlitelimab as Garijo tightens R&D discipline https://allsci.com/news/pharma/astrazeneca-bristol-myers-merger-and-squibb-held/ AllScien 2026-08-02T20:36:41.916652Z AstraZeneca, Bristol Myers Squibb explored potential merger, Financial Times reports